As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/14/07  Fresh Harvest Products, Inc.      10QSB       4/30/07    9:10M                                    Computerized Bo… Svcs/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 10QSB       Fresh Harvest Products Form 10QSB                   HTML    123K 
 2: 10QSB       Fresh Harvest Products Form 10QSB --                 PDF    684K 
                          fhp10qsbjun14-07                                       
 3: EX-10.1     Convertible Promissory Note                         HTML      6K 
 4: EX-10.2     Convertible Promissory Note                         HTML      6K 
 5: EX-10.3     Convertible Promissory Note                         HTML      6K 
 6: EX-10.4     Convertible Promissory Note                         HTML      6K 
 7: EX-10.5     Convertible Promissory Note                         HTML      6K 
 8: EX-31       Certification per Sarbanes-Oxley Act (Section 302)  HTML     11K 
 9: EX-32       Certification per Sarbanes-Oxley Act (Section 906)  HTML      8K 

Exhibit 31.1

Certification Pursuant to Section 302 of Sarbanes Oxley Act of 2002

I, Michael Jordan Friedman, certify that:

(1) I have reviewed this Quarterly Report on Form 10-QSB of Fresh Harvest Products, Inc. (the “Registrant”);

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

(4) I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the  Registrant's internal control over financial reporting that occurred during the  Registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the  Registrant's internal control over financial reporting; and

 

(5)  I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the  Registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

/s/ Michael Jordan Friedman

_________________________________________

Michael Jordan Friedman, Chief Executive Officer

and Chief Financial Officer

Date: June 14, 2007

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/01/21  Innovative Medtech, Inc.          10-K       10/31/14   47:2.4M                                   Discount Edgar/FA
 2/01/21  Innovative Medtech, Inc.          10-K       10/31/13   48:2.4M                                   Discount Edgar/FA
 2/01/21  Innovative Medtech, Inc.          10-K       10/31/12   47:2.5M                                   Discount Edgar/FA